The relationship between synovial inflammation, structural pathology, and pain in post-traumatic osteoarthritis: differential effect of stem cell and hyaluronan treatment

Synovitis is implicated in the severity and progression of pain and structural pathology of osteoarthritis (OA). Increases in inflammatory or immune cell subpopulations including macrophages and lymphocytes have been reported in OA synovium, but how the particular subpopulations influence symptomati...

Full description

Saved in:
Bibliographic Details
Published inArthritis research & therapy Vol. 22; no. 1; p. 29
Main Authors Shu, Cindy C, Zaki, Sanaa, Ravi, Varshini, Schiavinato, Antonella, Smith, Margaret M, Little, Christopher B
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 14.02.2020
BioMed Central
BMC
Subjects
Analgesia
Animals
Arthritis
Bone marrow
Care and treatment
Cartilage
Diagnosis
Disease
Diseases
Enzymes
Gene expression
Genes
Health aspects
Histochemistry
House mouse
Hyaluronan
Hyaluronic acid
Inflammation
Lymphocytes
Macrophages
Medical examination
Mesenchymal stem cells
Osteoarthritis
Pain
Pain management
Pathology
Patient outcomes
Polymerase chain reaction
Setting (Literature)
Stem cell transplantation
Stem cells
Structural pathology
Surgery
Synovial inflammation
Synovial membrane
T cells
Time
Italy
Hyaluronan
Structural pathology
Pain
Osteoarthritis
Synovial inflammation
Mesenchymal stem cells
Online AccessGet full text

Cover

Abstract Synovitis is implicated in the severity and progression of pain and structural pathology of osteoarthritis (OA). Increases in inflammatory or immune cell subpopulations including macrophages and lymphocytes have been reported in OA synovium, but how the particular subpopulations influence symptomatic or structural OA disease progression is unclear. Two therapies, hyaluronan (HA) and mesenchymal stem cells (MSCs), have demonstrated efficacy in some clinical settings: HA acting as device to improve joint function and provide pain relief, while MSCs may have immunomodulatory and disease-modifying effects. We used these agents to investigate whether changes in pain sensitization or structural damage were linked to modulation of the synovial inflammatory response in post-traumatic OA. Skeletally mature C57BL6 male mice underwent medial-meniscal destabilisation (DMM) surgery followed by intra-articular injection of saline, a hyaluronan hexadecylamide derivative (Hymovis), bone marrow-derived stem cells (MSCs), or MSC + Hymovis. We quantified the progression of OA-related cartilage, subchondral bone and synovial histopathology, and associated pain sensitization (tactile allodynia). Synovial lymphocytes, monocyte/macrophages and their subpopulations were quantified by fluorescent-activated cell sorting (FACS), and the expression of key inflammatory mediators and catabolic enzyme genes quantified by real-time polymerase chain reaction (PCR). MSC but not Hymovis significantly reduced late-stage (12-week post-DMM) cartilage proteoglycan loss and structural damage. Allodynia was initially reduced by both treatments but significantly better at 8 and 12 weeks by Hymovis. Chondroprotection by MSCs was not associated with specific changes in synovial inflammatory cell populations but rather regulation of post-injury synovial Adamts4, Adamts5, Mmp3, and Mmp9 expression. Reduced acute post-injury allodynia with all treatments coincided with decreased synovial macrophage and T cell numbers, while longer-term effect on pain sensitization with Hymovis was associated with increased M2c macrophages. This therapeutic study in mice demonstrated a poor correlation between cartilage, bone or synovium (histo)pathology, and pain sensitization. Changes in the specific synovial inflammatory cell subpopulations may be associated with chronic OA pain sensitization, and a novel target for symptomatic treatment.
AbstractList Synovitis is implicated in the severity and progression of pain and structural pathology of osteoarthritis (OA). Increases in inflammatory or immune cell subpopulations including macrophages and lymphocytes have been reported in OA synovium, but how the particular subpopulations influence symptomatic or structural OA disease progression is unclear. Two therapies, hyaluronan (HA) and mesenchymal stem cells (MSCs), have demonstrated efficacy in some clinical settings: HA acting as device to improve joint function and provide pain relief, while MSCs may have immunomodulatory and disease-modifying effects. We used these agents to investigate whether changes in pain sensitization or structural damage were linked to modulation of the synovial inflammatory response in post-traumatic OA. Skeletally mature C57BL6 male mice underwent medial-meniscal destabilisation (DMM) surgery followed by intra-articular injection of saline, a hyaluronan hexadecylamide derivative (Hymovis), bone marrow-derived stem cells (MSCs), or MSC + Hymovis. We quantified the progression of OA-related cartilage, subchondral bone and synovial histopathology, and associated pain sensitization (tactile allodynia). Synovial lymphocytes, monocyte/macrophages and their subpopulations were quantified by fluorescent-activated cell sorting (FACS), and the expression of key inflammatory mediators and catabolic enzyme genes quantified by real-time polymerase chain reaction (PCR). MSC but not Hymovis significantly reduced late-stage (12-week post-DMM) cartilage proteoglycan loss and structural damage. Allodynia was initially reduced by both treatments but significantly better at 8 and 12 weeks by Hymovis. Chondroprotection by MSCs was not associated with specific changes in synovial inflammatory cell populations but rather regulation of post-injury synovial Adamts4, Adamts5, Mmp3, and Mmp9 expression. Reduced acute post-injury allodynia with all treatments coincided with decreased synovial macrophage and T cell numbers, while longer-term effect on pain sensitization with Hymovis was associated with increased M2c macrophages. This therapeutic study in mice demonstrated a poor correlation between cartilage, bone or synovium (histo)pathology, and pain sensitization. Changes in the specific synovial inflammatory cell subpopulations may be associated with chronic OA pain sensitization, and a novel target for symptomatic treatment.
Synovitis is implicated in the severity and progression of pain and structural pathology of osteoarthritis (OA). Increases in inflammatory or immune cell subpopulations including macrophages and lymphocytes have been reported in OA synovium, but how the particular subpopulations influence symptomatic or structural OA disease progression is unclear. Two therapies, hyaluronan (HA) and mesenchymal stem cells (MSCs), have demonstrated efficacy in some clinical settings: HA acting as device to improve joint function and provide pain relief, while MSCs may have immunomodulatory and disease-modifying effects. We used these agents to investigate whether changes in pain sensitization or structural damage were linked to modulation of the synovial inflammatory response in post-traumatic OA. Skeletally mature C57BL6 male mice underwent medial-meniscal destabilisation (DMM) surgery followed by intra-articular injection of saline, a hyaluronan hexadecylamide derivative (Hymovis), bone marrow-derived stem cells (MSCs), or MSC + Hymovis. We quantified the progression of OA-related cartilage, subchondral bone and synovial histopathology, and associated pain sensitization (tactile allodynia). Synovial lymphocytes, monocyte/macrophages and their subpopulations were quantified by fluorescent-activated cell sorting (FACS), and the expression of key inflammatory mediators and catabolic enzyme genes quantified by real-time polymerase chain reaction (PCR). MSC but not Hymovis significantly reduced late-stage (12-week post-DMM) cartilage proteoglycan loss and structural damage. Allodynia was initially reduced by both treatments but significantly better at 8 and 12 weeks by Hymovis. Chondroprotection by MSCs was not associated with specific changes in synovial inflammatory cell populations but rather regulation of post-injury synovial Adamts4, Adamts5, Mmp3, and Mmp9 expression. Reduced acute post-injury allodynia with all treatments coincided with decreased synovial macrophage and T cell numbers, while longer-term effect on pain sensitization with Hymovis was associated with increased M2c macrophages. This therapeutic study in mice demonstrated a poor correlation between cartilage, bone or synovium (histo)pathology, and pain sensitization. Changes in the specific synovial inflammatory cell subpopulations may be associated with chronic OA pain sensitization, and a novel target for symptomatic treatment.
Background Synovitis is implicated in the severity and progression of pain and structural pathology of osteoarthritis (OA). Increases in inflammatory or immune cell subpopulations including macrophages and lymphocytes have been reported in OA synovium, but how the particular subpopulations influence symptomatic or structural OA disease progression is unclear. Two therapies, hyaluronan (HA) and mesenchymal stem cells (MSCs), have demonstrated efficacy in some clinical settings: HA acting as device to improve joint function and provide pain relief, while MSCs may have immunomodulatory and disease-modifying effects. We used these agents to investigate whether changes in pain sensitization or structural damage were linked to modulation of the synovial inflammatory response in post-traumatic OA. Methods Skeletally mature C57BL6 male mice underwent medial-meniscal destabilisation (DMM) surgery followed by intra-articular injection of saline, a hyaluronan hexadecylamide derivative (Hymovis), bone marrow-derived stem cells (MSCs), or MSC + Hymovis. We quantified the progression of OA-related cartilage, subchondral bone and synovial histopathology, and associated pain sensitization (tactile allodynia). Synovial lymphocytes, monocyte/macrophages and their subpopulations were quantified by fluorescent-activated cell sorting (FACS), and the expression of key inflammatory mediators and catabolic enzyme genes quantified by real-time polymerase chain reaction (PCR). Results MSC but not Hymovis significantly reduced late-stage (12-week post-DMM) cartilage proteoglycan loss and structural damage. Allodynia was initially reduced by both treatments but significantly better at 8 and 12 weeks by Hymovis. Chondroprotection by MSCs was not associated with specific changes in synovial inflammatory cell populations but rather regulation of post-injury synovial Adamts4, Adamts5, Mmp3, and Mmp9 expression. Reduced acute post-injury allodynia with all treatments coincided with decreased synovial macrophage and T cell numbers, while longer-term effect on pain sensitization with Hymovis was associated with increased M2c macrophages. Conclusions This therapeutic study in mice demonstrated a poor correlation between cartilage, bone or synovium (histo)pathology, and pain sensitization. Changes in the specific synovial inflammatory cell subpopulations may be associated with chronic OA pain sensitization, and a novel target for symptomatic treatment.
Abstract Background Synovitis is implicated in the severity and progression of pain and structural pathology of osteoarthritis (OA). Increases in inflammatory or immune cell subpopulations including macrophages and lymphocytes have been reported in OA synovium, but how the particular subpopulations influence symptomatic or structural OA disease progression is unclear. Two therapies, hyaluronan (HA) and mesenchymal stem cells (MSCs), have demonstrated efficacy in some clinical settings: HA acting as device to improve joint function and provide pain relief, while MSCs may have immunomodulatory and disease-modifying effects. We used these agents to investigate whether changes in pain sensitization or structural damage were linked to modulation of the synovial inflammatory response in post-traumatic OA. Methods Skeletally mature C57BL6 male mice underwent medial-meniscal destabilisation (DMM) surgery followed by intra-articular injection of saline, a hyaluronan hexadecylamide derivative (Hymovis), bone marrow-derived stem cells (MSCs), or MSC + Hymovis. We quantified the progression of OA-related cartilage, subchondral bone and synovial histopathology, and associated pain sensitization (tactile allodynia). Synovial lymphocytes, monocyte/macrophages and their subpopulations were quantified by fluorescent-activated cell sorting (FACS), and the expression of key inflammatory mediators and catabolic enzyme genes quantified by real-time polymerase chain reaction (PCR). Results MSC but not Hymovis significantly reduced late-stage (12-week post-DMM) cartilage proteoglycan loss and structural damage. Allodynia was initially reduced by both treatments but significantly better at 8 and 12 weeks by Hymovis. Chondroprotection by MSCs was not associated with specific changes in synovial inflammatory cell populations but rather regulation of post-injury synovial Adamts4, Adamts5, Mmp3, and Mmp9 expression. Reduced acute post-injury allodynia with all treatments coincided with decreased synovial macrophage and T cell numbers, while longer-term effect on pain sensitization with Hymovis was associated with increased M2c macrophages. Conclusions This therapeutic study in mice demonstrated a poor correlation between cartilage, bone or synovium (histo)pathology, and pain sensitization. Changes in the specific synovial inflammatory cell subpopulations may be associated with chronic OA pain sensitization, and a novel target for symptomatic treatment.
Background Synovitis is implicated in the severity and progression of pain and structural pathology of osteoarthritis (OA). Increases in inflammatory or immune cell subpopulations including macrophages and lymphocytes have been reported in OA synovium, but how the particular subpopulations influence symptomatic or structural OA disease progression is unclear. Two therapies, hyaluronan (HA) and mesenchymal stem cells (MSCs), have demonstrated efficacy in some clinical settings: HA acting as device to improve joint function and provide pain relief, while MSCs may have immunomodulatory and disease-modifying effects. We used these agents to investigate whether changes in pain sensitization or structural damage were linked to modulation of the synovial inflammatory response in post-traumatic OA. Methods Skeletally mature C57BL6 male mice underwent medial-meniscal destabilisation (DMM) surgery followed by intra-articular injection of saline, a hyaluronan hexadecylamide derivative (Hymovis), bone marrow-derived stem cells (MSCs), or MSC + Hymovis. We quantified the progression of OA-related cartilage, subchondral bone and synovial histopathology, and associated pain sensitization (tactile allodynia). Synovial lymphocytes, monocyte/macrophages and their subpopulations were quantified by fluorescent-activated cell sorting (FACS), and the expression of key inflammatory mediators and catabolic enzyme genes quantified by real-time polymerase chain reaction (PCR). Results MSC but not Hymovis significantly reduced late-stage (12-week post-DMM) cartilage proteoglycan loss and structural damage. Allodynia was initially reduced by both treatments but significantly better at 8 and 12 weeks by Hymovis. Chondroprotection by MSCs was not associated with specific changes in synovial inflammatory cell populations but rather regulation of post-injury synovial Adamts4, Adamts5, Mmp3, and Mmp9 expression. Reduced acute post-injury allodynia with all treatments coincided with decreased synovial macrophage and T cell numbers, while longer-term effect on pain sensitization with Hymovis was associated with increased M2c macrophages. Conclusions This therapeutic study in mice demonstrated a poor correlation between cartilage, bone or synovium (histo)pathology, and pain sensitization. Changes in the specific synovial inflammatory cell subpopulations may be associated with chronic OA pain sensitization, and a novel target for symptomatic treatment. Keywords: Osteoarthritis, Synovial inflammation, Structural pathology, Pain, Mesenchymal stem cells, Hyaluronan
BACKGROUNDSynovitis is implicated in the severity and progression of pain and structural pathology of osteoarthritis (OA). Increases in inflammatory or immune cell subpopulations including macrophages and lymphocytes have been reported in OA synovium, but how the particular subpopulations influence symptomatic or structural OA disease progression is unclear. Two therapies, hyaluronan (HA) and mesenchymal stem cells (MSCs), have demonstrated efficacy in some clinical settings: HA acting as device to improve joint function and provide pain relief, while MSCs may have immunomodulatory and disease-modifying effects. We used these agents to investigate whether changes in pain sensitization or structural damage were linked to modulation of the synovial inflammatory response in post-traumatic OA. METHODSSkeletally mature C57BL6 male mice underwent medial-meniscal destabilisation (DMM) surgery followed by intra-articular injection of saline, a hyaluronan hexadecylamide derivative (Hymovis), bone marrow-derived stem cells (MSCs), or MSC + Hymovis. We quantified the progression of OA-related cartilage, subchondral bone and synovial histopathology, and associated pain sensitization (tactile allodynia). Synovial lymphocytes, monocyte/macrophages and their subpopulations were quantified by fluorescent-activated cell sorting (FACS), and the expression of key inflammatory mediators and catabolic enzyme genes quantified by real-time polymerase chain reaction (PCR). RESULTSMSC but not Hymovis significantly reduced late-stage (12-week post-DMM) cartilage proteoglycan loss and structural damage. Allodynia was initially reduced by both treatments but significantly better at 8 and 12 weeks by Hymovis. Chondroprotection by MSCs was not associated with specific changes in synovial inflammatory cell populations but rather regulation of post-injury synovial Adamts4, Adamts5, Mmp3, and Mmp9 expression. Reduced acute post-injury allodynia with all treatments coincided with decreased synovial macrophage and T cell numbers, while longer-term effect on pain sensitization with Hymovis was associated with increased M2c macrophages. CONCLUSIONSThis therapeutic study in mice demonstrated a poor correlation between cartilage, bone or synovium (histo)pathology, and pain sensitization. Changes in the specific synovial inflammatory cell subpopulations may be associated with chronic OA pain sensitization, and a novel target for symptomatic treatment.
ArticleNumber 29
Audience Academic
Author Ravi, Varshini
Shu, Cindy C
Zaki, Sanaa
Smith, Margaret M
Little, Christopher B
Schiavinato, Antonella
Author_xml – sequence: 1
  givenname: Cindy C
  surname: Shu
  fullname: Shu, Cindy C
  organization: Raymond Purves Bone and Joint Laboratory, Institute of Bone and Joint Research, Kolling Institute, Faculty of Medicine and Health, University of Sydney, Level 10 Kolling Building - B6, Royal North Shore Hospital, St. Leonards, NSW, 2065, Australia
– sequence: 2
  givenname: Sanaa
  surname: Zaki
  fullname: Zaki, Sanaa
  organization: Raymond Purves Bone and Joint Laboratory, Institute of Bone and Joint Research, Kolling Institute, Faculty of Medicine and Health, University of Sydney, Level 10 Kolling Building - B6, Royal North Shore Hospital, St. Leonards, NSW, 2065, Australia
– sequence: 3
  givenname: Varshini
  surname: Ravi
  fullname: Ravi, Varshini
  organization: Raymond Purves Bone and Joint Laboratory, Institute of Bone and Joint Research, Kolling Institute, Faculty of Medicine and Health, University of Sydney, Level 10 Kolling Building - B6, Royal North Shore Hospital, St. Leonards, NSW, 2065, Australia
– sequence: 4
  givenname: Antonella
  surname: Schiavinato
  fullname: Schiavinato, Antonella
  organization: Fidia Farmaceutici, S.p.A, Abano Terme, PD, Italy
– sequence: 5
  givenname: Margaret M
  surname: Smith
  fullname: Smith, Margaret M
  organization: Raymond Purves Bone and Joint Laboratory, Institute of Bone and Joint Research, Kolling Institute, Faculty of Medicine and Health, University of Sydney, Level 10 Kolling Building - B6, Royal North Shore Hospital, St. Leonards, NSW, 2065, Australia
– sequence: 6
  givenname: Christopher B
  orcidid: 0000-0002-0353-7634
  surname: Little
  fullname: Little, Christopher B
  email: christopher.little@sydney.edu.au
  organization: Raymond Purves Bone and Joint Laboratory, Institute of Bone and Joint Research, Kolling Institute, Faculty of Medicine and Health, University of Sydney, Level 10 Kolling Building - B6, Royal North Shore Hospital, St. Leonards, NSW, 2065, Australia. christopher.little@sydney.edu.au
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32059749$$D View this record in MEDLINE/PubMed
BookMark eNptkstu1DAUhiNURC_wAGxQJDYsmuK7ExZIVcWlUiU2ZW15kuMZV4k92E7RvBJPyUmnlBaRLHJs_-dL_pP_uDoIMUBVvabkjNJWvc-UEy0bwkjDKNUNe1YdUaHbRnHFDh7Vh9VxzjeEMNYx8aI65IzITovuqPp1vYE6wWiLjyFv_LZeQfkJEOq8C_HW27H2wY12mu4Up3Uuae7LnPBga8smjnG9O61tGHDpA4rrbcylKcnOS0tf4wqiTWWTfPH5Qz145yBBKAsbsO5LHR1yYap7GMc71mZnxznFYENdEtgyof5l9dzZMcOr--dJ9f3zp-uLr83Vty-XF-dXTS8VKY1l3Ar0N2gnRav5YCVQyVa9topYQlpLmOS91co6MQiuQVLNOVeKMqp1x0-qyz13iPbGbJOfbNqZaL2524hpbdCO70cwnXArBeDaljGBl3UgOgkOKy4EJcj6uGdt59UEQ482cHJPoE9Pgt-Ydbw1mjDeUoWAd_eAFH_MkIuZfF7GZAPEORvGpeyU5ESi9O0_0ps4p4CjWlSacZyK-KtaWzSA_zbie_sFas4VVYII0i2qs_-o8B5g8j2m0Hncf9JA9w19ijkncA8eKTFLWM0-rAbDapaw4jedVG8eD-eh4086-W_-jejV
CitedBy_id crossref_primary_10_1016_j_trim_2022_101625
crossref_primary_10_1016_j_jcjp_2022_100055
crossref_primary_10_1016_j_joca_2021_03_023
crossref_primary_10_1155_2020_7517219
crossref_primary_10_3389_fbioe_2022_994816
crossref_primary_10_3389_fphys_2021_663978
crossref_primary_10_1007_s00167_023_07320_3
crossref_primary_10_3389_fimmu_2022_907750
crossref_primary_10_3389_fimmu_2023_1164137
crossref_primary_10_3389_fmed_2021_684389
crossref_primary_10_1002_art_42351
crossref_primary_10_3390_cells9071571
crossref_primary_10_3389_fimmu_2021_763702
crossref_primary_10_1155_2022_9116175
crossref_primary_10_3390_ijms23158381
crossref_primary_10_1155_2022_4620254
crossref_primary_10_1111_os_13993
crossref_primary_10_1002_jccs_202000557
crossref_primary_10_1016_j_ultrasmedbio_2020_12_019
crossref_primary_10_1016_j_joca_2021_10_004
crossref_primary_10_1016_j_cej_2021_129140
crossref_primary_10_5114_reum_172211
crossref_primary_10_1016_j_joca_2023_07_013
crossref_primary_10_1126_scitranslmed_abj9837
crossref_primary_10_1186_s13075_023_03042_6
Cites_doi 10.1016/j.joca.2017.11.015
10.1002/art.38876
10.1016/j.joca.2018.10.014
10.1136/ard.2006.067470
10.1002/art.39529
10.1136/ard.2011.150243
10.1002/art.20558
10.1007/s00776-008-1279-6
10.1002/art.25002
10.1016/j.joca.2015.05.006
10.1002/art.37900
10.1186/s12974-017-0804-y
10.1387/ijdb.072352ns
10.1016/j.joca.2004.03.003
10.1016/j.joca.2011.02.014
10.1016/j.joca.2013.06.003
10.1016/j.joca.2016.05.021
10.1186/1749-799X-1-8
10.1002/art.23027
10.1002/art.39488
10.3899/jrheum.151068
10.1677/jme.0.0290023
10.1093/rheumatology/kev228
10.1016/j.joca.2018.02.906
10.1016/j.joca.2006.11.005
10.1038/nature03417
10.1038/nn.4053
10.1111/jcmm.13138
10.3727/096368912X653264
10.1111/jcmm.14632
10.1016/j.joca.2009.11.013
10.1089/wound.2012.0407
10.1186/ar1756
10.1038/nature03369
10.1002/art.39844
10.1038/nrrheum.2013.72
10.1038/nrrheum.2013.109
10.1002/art.33388
10.1002/art.22337
10.3390/ijms141019951
10.1002/art.34626
10.1002/art.40378
10.1016/j.joca.2014.03.016
10.1146/annurev.pa.20.040180.002301
10.1186/s13075-017-1229-9
10.1148/radiol.2523082197
10.1186/1744-8069-9-48
10.1172/JCI30765
10.1002/art.38614
10.1371/journal.pone.0051221
10.1371/journal.pone.0215830
10.1093/rheumatology/ken219
10.2741/2692
10.1186/s13075-015-0747-6
10.1016/j.biopha.2018.11.099
10.1016/j.joca.2014.05.022
10.1007/s11914-018-0477-1
10.4155/fsoa-2016-0034
ContentType Journal Article
Copyright COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2020
Copyright_xml – notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2020
DBID NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13075-020-2117-2
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Databases
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
PubMed
Publicly Available Content Database


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X7
  name: Health & Medical Collection (Proquest)
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1478-6362
EndPage 29
ExternalDocumentID oai_doaj_org_article_94fb6eef88224444afe495ef44a34410
A616404094
10_1186_s13075_020_2117_2
32059749
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Italy
GeographicLocations_xml – name: Italy
GrantInformation_xml – fundername: ;
– fundername: ;
  grantid: APP1063133; APP1102306
GroupedDBID ---
-5E
-5G
-A0
-BR
.GJ
0R~
23N
2WC
3V.
4.4
5GY
5VS
6J9
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
ABUWG
ACGFS
ACJQM
ACRMQ
ADBBV
ADINQ
ADUKV
AEGXH
AENEX
AFKRA
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIAM
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CS3
DIK
E3Z
EBD
EBLON
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
HZ~
IAO
IHR
INH
INR
ITC
KQ8
M1P
NPM
O5R
O5S
O9-
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
U2A
UKHRP
WOQ
Z7U
AAYXX
CITATION
7XB
8FK
AZQEC
DWQXO
K9.
PQEST
PQUKI
PRINS
7X8
5PM
AFPKN
ID FETCH-LOGICAL-c560t-a23a4205d7f54873da5e152bc7a60a008a0253ca76af4d437e517333661217793
IEDL.DBID RPM
ISSN 1478-6362
1478-6354
IngestDate Tue Oct 22 15:08:20 EDT 2024
Tue Sep 17 20:48:01 EDT 2024
Fri Oct 25 22:07:45 EDT 2024
Thu Oct 10 15:38:44 EDT 2024
Tue Nov 19 21:26:01 EST 2024
Tue Nov 12 23:30:39 EST 2024
Thu Nov 21 22:28:24 EST 2024
Wed Oct 16 00:46:06 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Hyaluronan
Structural pathology
Pain
Osteoarthritis
Synovial inflammation
Mesenchymal stem cells
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c560t-a23a4205d7f54873da5e152bc7a60a008a0253ca76af4d437e517333661217793
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-0353-7634
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023816/
PMID 32059749
PQID 2357234204
PQPubID 42876
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_94fb6eef88224444afe495ef44a34410
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7023816
proquest_miscellaneous_2355965305
proquest_journals_2357234204
gale_infotracmisc_A616404094
gale_infotracacademiconefile_A616404094
crossref_primary_10_1186_s13075_020_2117_2
pubmed_primary_32059749
PublicationCentury 2000
PublicationDate 2020-02-14
PublicationDateYYYYMMDD 2020-02-14
PublicationDate_xml – month: 02
  year: 2020
  text: 2020-02-14
  day: 14
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Arthritis research & therapy
PublicationTitleAlternate Arthritis Res Ther
PublicationYear 2020
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References AB Blom (2117_CR12) 2004; 12
HL Ma (2117_CR27) 2007; 15
Y Muramatsu (2117_CR35) 2014; 22
CR Harrell (2117_CR41) 2019; 109
Y Tang (2117_CR45) 2017; 21
CB Little (2117_CR11) 2013; 9
RE Sorge (2117_CR57) 2015; 18
EA Balazs (2117_CR36) 2004; 12
S Nadri (2117_CR28) 2007; 51
C Shu (2117_CR29) 2016; 2
DS Jevotovsky (2117_CR22) 2018; 26
RF Schelbergen (2117_CR23) 2014; 22
CB Little (2117_CR37) 2007; 117
F Barry (2117_CR21) 2013; 9
CC Shu (2117_CR25) 2016; 68
M Cake (2117_CR19) 2008; 13
H Stanton (2117_CR56) 2005; 434
CL Hill (2117_CR9) 2007; 66
CB Little (2117_CR34) 2009; 60
A Mathiessen (2117_CR2) 2017; 19
SA Bustin (2117_CR33) 2002; 29
AM Stoker (2117_CR39) 2006; 1
JF Bateman (2117_CR47) 2013; 65
SS Glasson (2117_CR55) 2005; 434
S. Roberts (2117_CR52) 2015; 23
RF Loeser (2117_CR64) 2012; 64
M Ter Huurne (2117_CR24) 2012; 64
AS Tsang (2117_CR31) 2019; 14
AA Young (2117_CR40) 2005; 7
TW O'Neill (2117_CR4) 2018; 16
S Glasson (2117_CR53) 2004; 50
MT Jackson (2117_CR18) 2014; 66
AM Malfait (2117_CR26) 2010; 18
M.J.M. Minten (2117_CR49) 2019; 27
M Rostovskaya (2117_CR46) 2012; 7
LHW Kung (2117_CR48) 2018; 70
IR Klein-Wieringa (2117_CR60) 2016; 43
RD McCurdy (2117_CR32) 2008; 12
T Neogi (2117_CR6) 2016; 68
LS Lohmander (2117_CR38) 2014; 66
BO Diekman (2117_CR43) 2013; 22
2117_CR3
FW Roemer (2117_CR7) 2011; 70
BJ de Lange-Brokaar (2117_CR10) 2016; 24
Access-Economics (2117_CR1) 2007
X Wang (2117_CR5) 2018; 26
JL Hsieh (2117_CR15) 2013; 14
AM Malfait (2117_CR17) 2013; 21
M Yang (2117_CR59) 2015; 6
A Sindrilaru (2117_CR62) 2013; 2
WJ Dixon (2117_CR30) 1980; 20
MM Smith (2117_CR20) 2008; 47
MK Majumdar (2117_CR54) 2007; 56
MA Rowe (2117_CR65) 2017; 69
AM Malfait (2117_CR16) 2015; 17
Q Sun (2117_CR44) 2019; 23
AB Blom (2117_CR13) 2007; 56
FW Roemer (2117_CR8) 2009; 252
PC Shen (2117_CR14) 2011; 19
P Jayaram (2117_CR42) 2018
J Lin (2117_CR50) 2018; 18
KK Bali (2117_CR51) 2013; 9
U Baddack-Werncke (2117_CR58) 2017; 14
FO Martinez (2117_CR61) 2008; 13
DF Remst (2117_CR63) 2015; 54
References_xml – volume: 26
  start-page: 165
  issue: 2
  year: 2018
  ident: 2117_CR5
  publication-title: Osteoarthr Cartil
  doi: 10.1016/j.joca.2017.11.015
  contributor:
    fullname: X Wang
– volume: 66
  start-page: 3337
  issue: 12
  year: 2014
  ident: 2117_CR18
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.38876
  contributor:
    fullname: MT Jackson
– volume: 27
  start-page: 71
  issue: 1
  year: 2019
  ident: 2117_CR49
  publication-title: Osteoarthritis and Cartilage
  doi: 10.1016/j.joca.2018.10.014
  contributor:
    fullname: M.J.M. Minten
– volume: 66
  start-page: 1599
  issue: 12
  year: 2007
  ident: 2117_CR9
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2006.067470
  contributor:
    fullname: CL Hill
– volume: 68
  start-page: 868
  issue: 4
  year: 2016
  ident: 2117_CR25
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.39529
  contributor:
    fullname: CC Shu
– volume: 70
  start-page: 1804
  issue: 10
  year: 2011
  ident: 2117_CR7
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2011.150243
  contributor:
    fullname: FW Roemer
– volume: 50
  start-page: 2547
  year: 2004
  ident: 2117_CR53
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20558
  contributor:
    fullname: S Glasson
– volume: 13
  start-page: 514
  issue: 6
  year: 2008
  ident: 2117_CR19
  publication-title: J Orthop Sci
  doi: 10.1007/s00776-008-1279-6
  contributor:
    fullname: M Cake
– volume: 60
  start-page: 3723
  issue: 12
  year: 2009
  ident: 2117_CR34
  publication-title: Arthritis Rheum
  doi: 10.1002/art.25002
  contributor:
    fullname: CB Little
– volume: 23
  start-page: 1622
  issue: 9
  year: 2015
  ident: 2117_CR52
  publication-title: Osteoarthritis and Cartilage
  doi: 10.1016/j.joca.2015.05.006
  contributor:
    fullname: S. Roberts
– volume: 65
  start-page: 1547
  issue: 6
  year: 2013
  ident: 2117_CR47
  publication-title: Arthritis Rheum
  doi: 10.1002/art.37900
  contributor:
    fullname: JF Bateman
– volume: 14
  start-page: 30
  issue: 1
  year: 2017
  ident: 2117_CR58
  publication-title: J Neuroinflammation
  doi: 10.1186/s12974-017-0804-y
  contributor:
    fullname: U Baddack-Werncke
– volume: 51
  start-page: 723
  issue: 8
  year: 2007
  ident: 2117_CR28
  publication-title: Int J Dev Biol
  doi: 10.1387/ijdb.072352ns
  contributor:
    fullname: S Nadri
– volume: 12
  start-page: 627
  issue: 8
  year: 2004
  ident: 2117_CR12
  publication-title: Osteoarthr Cartil
  doi: 10.1016/j.joca.2004.03.003
  contributor:
    fullname: AB Blom
– volume: 19
  start-page: 728
  issue: 6
  year: 2011
  ident: 2117_CR14
  publication-title: Osteoarthr Cartil
  doi: 10.1016/j.joca.2011.02.014
  contributor:
    fullname: PC Shen
– volume: 6
  start-page: 532
  year: 2015
  ident: 2117_CR59
  publication-title: Front Immunol
  contributor:
    fullname: M Yang
– volume: 21
  start-page: 1316
  issue: 9
  year: 2013
  ident: 2117_CR17
  publication-title: Osteoarthr Cartil
  doi: 10.1016/j.joca.2013.06.003
  contributor:
    fullname: AM Malfait
– volume: 24
  start-page: 1867
  issue: 11
  year: 2016
  ident: 2117_CR10
  publication-title: Osteoarthr Cartil
  doi: 10.1016/j.joca.2016.05.021
  contributor:
    fullname: BJ de Lange-Brokaar
– volume: 1
  start-page: 8
  year: 2006
  ident: 2117_CR39
  publication-title: J Orthop Surg Res
  doi: 10.1186/1749-799X-1-8
  contributor:
    fullname: AM Stoker
– volume: 56
  start-page: 3670
  issue: 11
  year: 2007
  ident: 2117_CR54
  publication-title: Arthritis Rheum
  doi: 10.1002/art.23027
  contributor:
    fullname: MK Majumdar
– volume: 68
  start-page: 654
  issue: 3
  year: 2016
  ident: 2117_CR6
  publication-title: Arthr Rheumatol
  doi: 10.1002/art.39488
  contributor:
    fullname: T Neogi
– volume: 43
  start-page: 771
  issue: 4
  year: 2016
  ident: 2117_CR60
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.151068
  contributor:
    fullname: IR Klein-Wieringa
– volume: 29
  start-page: 23
  issue: 1
  year: 2002
  ident: 2117_CR33
  publication-title: J Mol Endocrinol
  doi: 10.1677/jme.0.0290023
  contributor:
    fullname: SA Bustin
– volume: 54
  start-page: 1954
  issue: 11
  year: 2015
  ident: 2117_CR63
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kev228
  contributor:
    fullname: DF Remst
– volume-title: Bone marrow-derived and adipose-derived mesenchymal stem cell therapy in primary knee osteoarthritis: a narrative review
  year: 2018
  ident: 2117_CR42
  contributor:
    fullname: P Jayaram
– ident: 2117_CR3
– volume: 26
  start-page: 711
  issue: 6
  year: 2018
  ident: 2117_CR22
  publication-title: Osteoarthr Cartil
  doi: 10.1016/j.joca.2018.02.906
  contributor:
    fullname: DS Jevotovsky
– volume: 15
  start-page: 695
  issue: 6
  year: 2007
  ident: 2117_CR27
  publication-title: Osteoarthr Cartil
  doi: 10.1016/j.joca.2006.11.005
  contributor:
    fullname: HL Ma
– volume: 434
  start-page: 648
  issue: 7033
  year: 2005
  ident: 2117_CR56
  publication-title: Nature
  doi: 10.1038/nature03417
  contributor:
    fullname: H Stanton
– volume: 18
  start-page: 1081
  issue: 8
  year: 2015
  ident: 2117_CR57
  publication-title: Nat Neurosci
  doi: 10.1038/nn.4053
  contributor:
    fullname: RE Sorge
– volume: 21
  start-page: 2153
  issue: 9
  year: 2017
  ident: 2117_CR45
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.13138
  contributor:
    fullname: Y Tang
– volume: 22
  start-page: 1395
  issue: 8
  year: 2013
  ident: 2117_CR43
  publication-title: Cell Transplant
  doi: 10.3727/096368912X653264
  contributor:
    fullname: BO Diekman
– volume: 23
  start-page: 7592
  issue: 11
  year: 2019
  ident: 2117_CR44
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.14632
  contributor:
    fullname: Q Sun
– volume: 18
  start-page: 572
  issue: 4
  year: 2010
  ident: 2117_CR26
  publication-title: Osteoarthr Cartil
  doi: 10.1016/j.joca.2009.11.013
  contributor:
    fullname: AM Malfait
– volume: 2
  start-page: 357
  issue: 7
  year: 2013
  ident: 2117_CR62
  publication-title: Adv Wound Care
  doi: 10.1089/wound.2012.0407
  contributor:
    fullname: A Sindrilaru
– volume: 7
  start-page: R852
  issue: 4
  year: 2005
  ident: 2117_CR40
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar1756
  contributor:
    fullname: AA Young
– volume: 434
  start-page: 644
  issue: 7033
  year: 2005
  ident: 2117_CR55
  publication-title: Nature
  doi: 10.1038/nature03369
  contributor:
    fullname: SS Glasson
– volume: 69
  start-page: 352
  issue: 2
  year: 2017
  ident: 2117_CR65
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.39844
  contributor:
    fullname: MA Rowe
– volume: 9
  start-page: 485
  issue: 8
  year: 2013
  ident: 2117_CR11
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2013.72
  contributor:
    fullname: CB Little
– volume: 9
  start-page: 584
  issue: 10
  year: 2013
  ident: 2117_CR21
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2013.109
  contributor:
    fullname: F Barry
– volume: 64
  start-page: 705
  issue: 3
  year: 2012
  ident: 2117_CR64
  publication-title: Arthritis Rheum
  doi: 10.1002/art.33388
  contributor:
    fullname: RF Loeser
– volume: 56
  start-page: 147
  issue: 1
  year: 2007
  ident: 2117_CR13
  publication-title: Arthritis Rheum
  doi: 10.1002/art.22337
  contributor:
    fullname: AB Blom
– volume: 14
  start-page: 19951
  issue: 10
  year: 2013
  ident: 2117_CR15
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms141019951
  contributor:
    fullname: JL Hsieh
– volume: 64
  start-page: 3604
  issue: 11
  year: 2012
  ident: 2117_CR24
  publication-title: Arthritis Rheum
  doi: 10.1002/art.34626
  contributor:
    fullname: M Ter Huurne
– volume: 70
  start-page: 383
  issue: 3
  year: 2018
  ident: 2117_CR48
  publication-title: Arthritis Rheumat
  doi: 10.1002/art.40378
  contributor:
    fullname: LHW Kung
– volume: 22
  start-page: 831
  issue: 6
  year: 2014
  ident: 2117_CR35
  publication-title: Osteoarthr Cartil
  doi: 10.1016/j.joca.2014.03.016
  contributor:
    fullname: Y Muramatsu
– volume: 20
  start-page: 441
  year: 1980
  ident: 2117_CR30
  publication-title: Annu Rev Pharmacol Toxicol
  doi: 10.1146/annurev.pa.20.040180.002301
  contributor:
    fullname: WJ Dixon
– volume: 18
  start-page: 5594
  issue: 6
  year: 2018
  ident: 2117_CR50
  publication-title: Mol Med Rep
  contributor:
    fullname: J Lin
– volume: 19
  start-page: 18
  issue: 1
  year: 2017
  ident: 2117_CR2
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-017-1229-9
  contributor:
    fullname: A Mathiessen
– volume: 252
  start-page: 772
  issue: 3
  year: 2009
  ident: 2117_CR8
  publication-title: Radiology
  doi: 10.1148/radiol.2523082197
  contributor:
    fullname: FW Roemer
– volume: 9
  start-page: 48
  year: 2013
  ident: 2117_CR51
  publication-title: Mol Pain
  doi: 10.1186/1744-8069-9-48
  contributor:
    fullname: KK Bali
– volume: 117
  start-page: 1627
  issue: 6
  year: 2007
  ident: 2117_CR37
  publication-title: J Clin Invest
  doi: 10.1172/JCI30765
  contributor:
    fullname: CB Little
– volume: 66
  start-page: 1820
  issue: 7
  year: 2014
  ident: 2117_CR38
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.38614
  contributor:
    fullname: LS Lohmander
– volume: 12
  start-page: 1215
  issue: 1
  year: 2008
  ident: 2117_CR32
  publication-title: Gene Ther Mol Biol
  contributor:
    fullname: RD McCurdy
– volume: 7
  start-page: e51221
  issue: 12
  year: 2012
  ident: 2117_CR46
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0051221
  contributor:
    fullname: M Rostovskaya
– volume-title: Access Econmics Report
  year: 2007
  ident: 2117_CR1
  contributor:
    fullname: Access-Economics
– volume: 14
  start-page: e0215830
  issue: 4
  year: 2019
  ident: 2117_CR31
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0215830
  contributor:
    fullname: AS Tsang
– volume: 12
  start-page: 278
  year: 2004
  ident: 2117_CR36
  publication-title: Surg Technol Int
  contributor:
    fullname: EA Balazs
– volume: 47
  start-page: 1172
  issue: 8
  year: 2008
  ident: 2117_CR20
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/ken219
  contributor:
    fullname: MM Smith
– volume: 13
  start-page: 453
  year: 2008
  ident: 2117_CR61
  publication-title: Front Biosci
  doi: 10.2741/2692
  contributor:
    fullname: FO Martinez
– volume: 17
  start-page: 225
  year: 2015
  ident: 2117_CR16
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-015-0747-6
  contributor:
    fullname: AM Malfait
– volume: 109
  start-page: 2318
  year: 2019
  ident: 2117_CR41
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2018.11.099
  contributor:
    fullname: CR Harrell
– volume: 22
  start-page: 1158
  issue: 8
  year: 2014
  ident: 2117_CR23
  publication-title: Osteoarthr Cartil
  doi: 10.1016/j.joca.2014.05.022
  contributor:
    fullname: RF Schelbergen
– volume: 16
  start-page: 611
  issue: 5
  year: 2018
  ident: 2117_CR4
  publication-title: Curr Osteoporos Rep
  doi: 10.1007/s11914-018-0477-1
  contributor:
    fullname: TW O'Neill
– volume: 2
  start-page: Fso142
  issue: 4
  year: 2016
  ident: 2117_CR29
  publication-title: Future science OA
  doi: 10.4155/fsoa-2016-0034
  contributor:
    fullname: C Shu
SSID ssj0022924
Score 2.494246
Snippet Synovitis is implicated in the severity and progression of pain and structural pathology of osteoarthritis (OA). Increases in inflammatory or immune cell...
Background Synovitis is implicated in the severity and progression of pain and structural pathology of osteoarthritis (OA). Increases in inflammatory or immune...
BACKGROUNDSynovitis is implicated in the severity and progression of pain and structural pathology of osteoarthritis (OA). Increases in inflammatory or immune...
Abstract Background Synovitis is implicated in the severity and progression of pain and structural pathology of osteoarthritis (OA). Increases in inflammatory...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 29
SubjectTerms Analgesia
Animals
Arthritis
Bone marrow
Care and treatment
Cartilage
Diagnosis
Disease
Diseases
Enzymes
Gene expression
Genes
Health aspects
Histochemistry
House mouse
Hyaluronan
Hyaluronic acid
Inflammation
Lymphocytes
Macrophages
Medical examination
Mesenchymal stem cells
Osteoarthritis
Pain
Pain management
Pathology
Patient outcomes
Polymerase chain reaction
Setting (Literature)
Stem cell transplantation
Stem cells
Structural pathology
Surgery
Synovial inflammation
Synovial membrane
T cells
Time
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9swFBejh7HL2PfcdUWFwWDU1JVkSd6tKyulsJ1W6E3ItkwCww5NMui_tL9yvyfZIWaHXZaTE8lGft8vevo9xj4obb2GG8irUNlceQ-VqmyXV6ppK7hcW7exQPa7vr5VN3fl3V6rL6oJS_DAiXBnlepqHUJnqdwRH98FxPShw5WEK0_ZeiGmZGpMtQTSinEP89zqszUstaGTyEWOhMfkYuaFIlj_3yZ5zyfN6yX3HNDVM_Z0jBz5RVrxc_Yo9C_Y42_j3vhL9hsc5_dTbdtiueJjDRZfP_TDL8gZhzRBANJhxVOeoGMJdoNTX-L4__op932Lr8sek_lqWG9yrGUbcV05nQcZQLFFBEL6zKfmKht6dioM4UPHCRqa04ZAfNbiwf_c3iPe7_muqP0Vu736-uPyOh87MeQNIqJN7oX0ShRlazrKcGTrywDHXzfG68IjjPAInWTjjfadapU0oTw3UkpN-GQGJuA1O-iHPrxlXDZF0QrZWtoANVZB7YNqyy7Ulba11Bn7NHHGrRLghouJitUusdGBjY7Y6ETGvhDvdhMJKzv-AAlyowS5f0lQxj4S5x1pNEja-PFgAtZL2FjuQiOlLCgPztjRbCY0sZkPT7LjRkuwdgQnJCSIh-GT3TDdSdVtfRi2cU5Z6RKmN2NvkqjtXkmC7Mj5qoyZmRDO3nk-0i8XESfcxHhMH_4PIr1jTwSpD7XCUUfsABIa3iMc29THUfP-AAXfM_c
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9swFBZbB2Mvpbu764YGg8GoqGPJuvRldGOlDLanFfImZEteAsXO4qTQv9RfuXNkOa0ZLE-JpRjZ565z9B1CPgipnQQzwEwwmgnnQKSMbpgRtTdgcnXlY4HsT3lxKb7Py3nacOtTWeWoE6Oi9l2Ne-QnCMtScFHk4vPqD8OuUZhdTS00HpJHswJMOfCzmt8FXIUZmtoKiJTAsIqU1ZxpedKD7lZ4NjlnEAIpVkzsUoTv_1dJ37NS0wrKeybp_IDsJ1-Sng3Ef0oehPYZefwjZcufk1vgAboeq90WyxVNVVm0v2m7a-A8CvwFLDEcXzymA5gsAnFQ7FQcd9yPqWs9_Fy2MJmuun7DYC3biPRK8YRIB8y3iNBIp3Rst7LBew-lIrRrKIJFU0wRxHstbtzVdg0RQEt3Ze4vyOX5t19fL1jqzcBq8JE2zBXcATFKrxqMebh3ZQBXoKqVk7kDx8KBM8Vrp6RrhBdchXKmOOcSEcsUKIWXZK_t2vCaUF7nuS-415gSVVqAIgjCl02ojNQVlxn5NFLGrgYIDhtDFy3tQEYLZLRIRltk5AvSbjcR0bPjhW792yZhtEY0lQyh0VhCCx_XBIgTQwPfOLiHeUY-IuUtyji80tqlowqwXkTLsmcSgswcI-OMHE1mgmzW0-GRd2zSDb294-SMvN8N4z-x3q0N3TbOKY0sQRln5NXAartH4vDaIQo0GVETJpw883SkXS4icriKHpo8_P-y3pAnBQoGtr0RR2QPeC-8BddrU72L8vUX6aUtdw
  priority: 102
  providerName: ProQuest
Title The relationship between synovial inflammation, structural pathology, and pain in post-traumatic osteoarthritis: differential effect of stem cell and hyaluronan treatment
URI https://www.ncbi.nlm.nih.gov/pubmed/32059749
https://www.proquest.com/docview/2357234204
https://search.proquest.com/docview/2355965305
https://pubmed.ncbi.nlm.nih.gov/PMC7023816
https://doaj.org/article/94fb6eef88224444afe495ef44a34410
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZtB2MvY_d564IGg8GoG9eSJXtvaWkpg5YyFsibkG25CbR2yGXQv7Rfue_IdqjZ2_JgYks2ss7dOvoOY1-kSq2CGQgzl6WhtBYilaVVmMmizGBy07z0CbLX6nIqf8yS2R5L-r0wPmm_yBfH9d39cb2Y-9zK5X0x7vPExjdXZ9obGjXeZ_swv32I3kVZcdZWspUIj2BNZbeUeZKq8RoKW9OG5ChE3KNDKmUj4oh86mxglzx8_79K-pGVGmZQPjJJFy_Y886X5JN2zC_ZnqtfsadX3Wr5a_YHPMBXfbbbfLHkXVYWXz_UzW9wHgd_gSXa7YtHvAWTJSAOTpWK_Rf3I27rEqeLGp35sllvQoxl65FeOe0QaTBncw-N9J335VY29Ow2VYQ3FSewaE5LBP5Z8wd7t10hAqj5Ls39DZtenP86uwy72gxhAR9pE9pYWImpK3VFMY8obeLgCuSFtiqycCwsnClRWK1sJUsptEtOtBBCEWKZhlJ4yw7qpnbvGRdFFJWxKFNaEtWphCJwskwql2cqzYUK2LeeMmbZQnAYH7qkyrQUNaCoIYqaOGCnRLtdR0LP9hea1a3peMhkssqVc1VKKbT42cohTnQV_gm4h1HAvhLlDck4prSw3VYFjJfQssxEIciMKDIO2OGgJ2SzGDb3vGM63bA2BDAUC0wemj_vmulOynerXbP1fZJMJVDGAXvXstrulXqODZgeMOHgnYctECSPHN4Jzof_vvMjexaT-FBFHHnIDsCW7hO8sk0-gizO9Ig9OT2_vvk58t82Rl4ycZzGk79cozrl
link.rule.ids 230,314,727,780,784,864,885,2102,12056,21388,27924,27925,31719,31720,33744,33745,43310,43805,53791,53793
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED9BJwEviG8CA4yEhIQWLYsdO-YFbWhTga1CaJP2ZjmJQyuhpDQt0v4l_kruHKcsQqJPbexGTu7bd_4dwBshcyvRDMTa6TwW1qJI6byOtSgrjSY3LypfIDuT0wvx-TK7DBtuXSirHHSiV9RVW9Ie-T7BsqRcpIn4sPwZU9coyq6GFho3YYeQ07MJ7Bwdz75-24Zcqe7b2gqMldC0ipDXPMjlfofaW9Hp5CTGIEjF6cgyeQD_f9X0NTs1rqG8ZpRO7sHd4E2yw5789-GGax7ArbOQL38Iv5EL2Gqod5svlizUZbHuqml_Ie8x5DBkiv4A4x7r4WQJioNRr2K_577HbFPhz0WDk9my7dYxrmXjsV4ZnRFpkf3mHhzpPRsarqzp3n2xCGtrRnDRjJIE_l7zK_tjs8IYoGHbQvdHcHFyfP5xGofuDHGJXtI6tim3SI6sUjVFPbyymUNnoCiVlYlF18KiO8VLq6StRSW4ctmB4pxLwixTqBYew6RpG_cUGC-TpEp5lVNSVOUCVYETVVa7Qsu84DKCdwNlzLIH4TA-eMml6clokIyGyGjSCI6IdtuJhJ_tL7Sr7yaIo9GiLqRzdU5FtPixtcNI0dX4jaODmETwlihvSMrxlZY2HFbA9RJeljmUGGYmFBtHsDuaidJZjocH3jFBO3TmLy9H8Ho7TP-kirfGtRs_J9MyQ3UcwZOe1baPxPG1YxyoI1AjJhw983ikWcw9drjyPpp89v9lvYLb0_OzU3P6afblOdxJSUioCY7YhQnyoXuBjti6eBmk7Q9UPzHN
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSBUXxLuBAkZCQkJNk8aOHXMrhVV5tOqBSr1ZTuywK7XOah9I_Uv8SmYcZ7URN_a0u3YixzPjmYk_f0PIOy4qI8ANpMqpKuXGgEmpqk0Vb6wCl1vVNgBkz8XpJf92VV5tlfoKoP2mnh3665tDP5sGbOX8pskGnFh2cXYig6MR2dy22V1yr2SgZEOiHnOtQvX1bDkkSeBTedzQPKpEtoRlW-Kx5DyF7EemWNCGFTlG1mrknQKJ_79L9ZavGuMotxzT5CF5ECNKetyP_BG54_xjsnsW98yfkD-gCXQxYN6mszmN2Cy6vPXdb9A_CloGitEfYjygPaUs0nFQrFcc3rsfUOMt_Jx56Ezn3XKVwljWge-V4jmRDmZuGgiSPtKh6MoK790DRmjXUqSMprhREO41vTXX6wXkAZ5uwO5PyeXky8-T0zRWaEgbiJRWqSmY4TB1VraY-TBrSgcBQd1II3ID4YWBkIo1RgrTcsuZdOWRZIwJ5C2TILVnZMd33u0Rypo8twWzFW6MyorDcuC4LVtXK1HVTCTkwyAZPe-JOHRIYCqhe4lqkKhGieoiIZ9QdpuOyKEd_ugWv3TUJK14Wwvn2gqBtPAxrYNs0bXwjUGQmCfkPUpeo6XDlDYmHliA8SJnlj4WkGrmmB8nZH_UEyy0GTcPuqPjCrHUSDNUMJg8aH67acYrEfXmXbcOfUolSliSE_K8V7XNIw0amxA5UsLRM49bwJwCf3g0nxf_feUbsnvxeaJ_fD3__pLcL9CSsEQO3yc7oKHuFYRpq_p1MMi_eTk67g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+relationship+between+synovial+inflammation%2C+structural+pathology%2C+and+pain+in+post-traumatic+osteoarthritis%3A+differential+effect+of+stem+cell+and+hyaluronan+treatment&rft.jtitle=Arthritis+research+%26+therapy&rft.au=Shu%2C+Cindy+C.&rft.au=Zaki%2C+Sanaa&rft.au=Ravi%2C+Varshini&rft.au=Schiavinato%2C+Antonella&rft.date=2020-02-14&rft.pub=BioMed+Central&rft.issn=1478-6354&rft.eissn=1478-6362&rft.volume=22&rft_id=info:doi/10.1186%2Fs13075-020-2117-2&rft_id=info%3Apmid%2F32059749&rft.externalDBID=PMC7023816
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6362&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6362&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6362&client=summon